Autopsy report · NCT03707444
A Pilot Trial of Scrambler Therapy for Pain Associated With Pancreas Cancer
Cause of deathStaffing, sites or logistics, also safety
“The PI is dealing with recurrent cancer and multiple side effects of treatment. N o one else to do the study.”
Life of this trial
- Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.
Vital statistics
- Status
- Withdrawn
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Sponsor type
- University, hospital or other
- Conditions
- Cancer Pancreas; Pain Syndrome; Cancer Related Pain
- Interventions
- Scrambler Therapy Device
- Participants
- 0
- Sites
- 1
- Countries
- United States
Trials that died the same way
- Superficial Cervical Plexus Block for Improved Outcomes in Pediatric Otolaryngologic Surgery
“The current PI is leaving the study. Study team is awaiting FDA PI change approval.” - Endocrine Therapy + OSI-906 With or Without Erlotinib for Hormone-Sensitive Metastatic Breast Cancer
“PI closed study early, all patients experienced severe toxicities and progressed” - Carry-over Effects of Repetitively Applied Transcutaneous Spinal Cord Stimulation on Spasticity
“Study terminated by the PIs due to unexpected outcomes” - Cetuximab in Third Line for Mutant APC, TP53 and RAS Patients With Refractory Metastatic Colorectal Cancer
“PI Determination - Slow recruitment, funding concerns, poor response to treatment” - A Study of the Use of IV Scopolamine to Augment the Efficacy of Electroconvulsive Therapy (ECT)
“This was an inpatient study, but PI left inpatient service at MGH”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.